ArticleOncotarget2016

The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients.

Weiwei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.